Evidence map›Paper›PMID 35874106›Full record

ArticleCanadian respiratory journal2022

Polygonatum Polysaccharide Regulates Macrophage Polarization and Improves LPS-Induced Acute Lung Injury through TLR4-MAPK/NF-

Weizheng Zhou, Jiang Hong, Tao Liu, Mengxing Li, Hai Jin, Xiaowei Wang

Open access · goldAbstract read
In one paragraph

Article in Canadian respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Lipopolysaccharide-mediated macrophage polarization, conserved pathogenesis, and implications for peripheral neuropathy: a systematic review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Pooled it
  2. Article
  3. Review
  4. Immune-Enhancing Effects ofCurrent issues in molecular biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Weizheng ZhouDepartment of Thoracic Surgery, Changhai Hospital, Shanghai 200433, China.
Jiang HongDepartment of Thoracic Surgery, Changhai Hospital, Shanghai 200433, China.
Tao LiuDepartment of Thoracic Surgery, Changhai Hospital, Shanghai 200433, China.
Mengxing LiDepartment of Thoracic Surgery, Changhai Hospital, Shanghai 200433, China.
Hai JinDepartment of Thoracic Surgery, Changhai Hospital, Shanghai 200433, China.ORCID 0000-0003-0430-2834
Xiaowei WangDepartment of Thoracic Surgery, Changhai Hospital, Shanghai 200433, China.ORCID 0000-0002-6287-6679
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the effects of polygonatum sibiricum polysaccharides (PSPs) on the polarization of macrophages to M1 and M2 phenotypes and their potential mechanism. Methods: PSPs samples were prepared through water extraction and alcohol precipitation assay. The properties of PSPs were identified and analyzed by high-performance liquid chromatography, FT-IR, and NMR assay. Then, the effects of PSPs on mouse macrophage RAW264.7 viability were measured by CCK-8 assay. The cells were randomly divided into the control group, PSPs group, LPS group, and LPS + PSPs group. M1 phenotype polarization of RAW264.7 cells was induced by LPS treatment. The effects of various treatments on expression of M2 phenotype CD206, activation of TLR4-MAPK/NF- Results: The concentrations of PSPs lower than 100 Conclusion: PSPs could suppress TLR4-MAPK/NF-

Indexed as

Acute Lung InjuryPolygonatumAnimalsInterleukin-6LipopolysaccharidesMacrophagesMiceNF-kappa BPolysaccharidesSpectroscopy, Fourier Transform InfraredToll-Like Receptor 4Tumor Necrosis Factor-alphaInterleukin-6LipopolysaccharidesNF-kappa BPolysaccharidesTlr4 protein, mouseToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID35874106
PMCPMC9303503
OpenAlexW4285494594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.